X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1406) 1406
Publication (28) 28
Newspaper Article (27) 27
Patent (7) 7
Book Chapter (5) 5
Book / eBook (4) 4
Conference Proceeding (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (687) 687
heart failure (581) 581
cardiac & cardiovascular systems (534) 534
male (385) 385
female (338) 338
mortality (301) 301
aged (297) 297
middle aged (271) 271
cardiovascular (183) 183
heart failure - physiopathology (181) 181
prognosis (177) 177
chronic disease (157) 157
cachexia (143) 143
medicine, general & internal (139) 139
heart failure - drug therapy (137) 137
heart failure - complications (116) 116
risk factors (115) 115
cardiac patients (111) 111
prospective studies (106) 106
heart failure - blood (105) 105
heart failure - mortality (101) 101
survival (100) 100
internal medicine (99) 99
chronic heart failure (95) 95
follow-up studies (89) 89
sarcopenia (89) 89
treatment outcome (86) 86
abridged index medicus (85) 85
chronic heart-failure (84) 84
heart failure - diagnosis (84) 84
outcomes (83) 83
aged, 80 and over (81) 81
care and treatment (78) 78
hospitalization (74) 74
risk (74) 74
adult (73) 73
diagnosis (71) 71
association (69) 69
cardiology (69) 69
biomarkers (67) 67
biomarkers - blood (67) 67
disease (66) 66
quality of life (66) 66
anemia (65) 65
analysis (64) 64
exercise (64) 64
cytokines (63) 63
animals (62) 62
heart failure - therapy (62) 62
prevalence (60) 60
medicine & public health (59) 59
therapy (59) 59
geriatrics & gerontology (58) 58
metabolism (58) 58
patients (56) 56
guidelines (55) 55
heart failure - epidemiology (55) 55
skeletal-muscle (55) 55
heart failure - metabolism (54) 54
heart-failure (54) 54
tumor-necrosis-factor (54) 54
body mass index (53) 53
cancer (52) 52
double-blind (52) 52
double-blind method (52) 52
health aspects (52) 52
studies (52) 52
cardiology and cardiovascular medicine (51) 51
clinical trials (50) 50
european-society (49) 49
stroke (49) 49
drug therapy (48) 48
cardiovascular disease (47) 47
research (47) 47
chronic kidney-disease (46) 46
heart (46) 46
medical colleges (46) 46
obesity (46) 46
inflammation (45) 45
physiological aspects (45) 45
trial (45) 45
comorbidity (44) 44
exercise capacity (44) 44
oncology (44) 44
proportional hazards models (44) 44
survival analysis (44) 44
body composition (43) 43
cachexia - etiology (43) 43
left-ventricular dysfunction (43) 43
musculoskeletal system (43) 43
management (42) 42
medicin och hälsovetenskap (42) 42
quality-of-life (42) 42
stroke volume (42) 42
iron deficiency (41) 41
medical and health sciences (41) 41
heart diseases (40) 40
medical research (40) 40
morbidity (40) 40
original (40) 40
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1427) 1427
German (41) 41
Spanish (7) 7
Polish (5) 5
French (2) 2
Russian (2) 2
Danish (1) 1
Greek (1) 1
Japanese (1) 1
Norwegian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 12, pp. 1119 - 1131
Patients with myocardial infarction and a high-sensitivity CRP level of 2 mg or more per liter were assigned to one of three canakinumab doses or placebo. The... 
no | C-REACTIVE PROTEIN | MEDICINE, GENERAL & INTERNAL | HEART-DISEASE | MYOCARDIAL-INFARCTION | STATIN THERAPY | CLONAL HEMATOPOIESIS | INFLAMMATION | CARDIOVASCULAR-DISEASE | INTERLEUKIN-1-BETA INHIBITION | RISK | CORONARY-ARTERY-DISEASE | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Male | Secondary Prevention | Infection - etiology | Incidence | Dose-Response Relationship, Drug | Anti-Inflammatory Agents - adverse effects | C-Reactive Protein - metabolism | Lipids - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Anti-Inflammatory Agents - administration & dosage | Female | Neutropenia - chemically induced | Interleukin-1beta - antagonists & inhibitors | Stroke - prevention & control | Atherosclerosis - drug therapy | Double-Blind Method | Interleukin-1beta - immunology | Atherosclerosis - blood | Myocardial Infarction - drug therapy | Antibodies, Monoclonal - administration & dosage | Aged | Myocardial Infarction - prevention & control | Myocardial infarction | Cerebral infarction | Stroke | Heart attacks | C-reactive protein | Cytokines | Clinical trials | Cardiovascular disease | Innate immunity | Inflammation | Angina | Angina pectoris | Thrombosis | Cholesterol | Disease prevention | Proteins | Arteriosclerosis | Atherosclerosis | Cardiovascular diseases | Health risk assessment | Drug therapy | Drug dosages | Klinisk medicin | Clinical Medicine
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 2012, Volume 366, Issue 20, pp. 1859 - 1869
Journal Article
The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 489 - 495
Journal Article
Journal of the American Medical Directors Association, ISSN 1525-8610, 2011, Volume 12, Issue 6, pp. 403 - 409
Journal Article